ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,061 | -29.5% | 1,083 | 0.0% | 0.00% | – |
| Q2 2023 | $1,506 | -23.0% | 1,083 | -12.0% | 0.00% | – |
| Q1 2023 | $1,956 | -91.6% | 1,230 | -67.1% | 0.00% | – |
| Q4 2022 | $23,294 | -44.5% | 3,739 | -40.0% | 0.00% | – |
| Q3 2022 | $42,000 | +16.7% | 6,232 | +10.3% | 0.00% | – |
| Q2 2022 | $36,000 | +71.4% | 5,648 | +25.7% | 0.00% | – |
| Q1 2022 | $21,000 | +250.0% | 4,492 | +247.1% | 0.00% | – |
| Q4 2021 | $6,000 | -89.1% | 1,294 | -71.7% | 0.00% | – |
| Q3 2021 | $55,000 | -45.5% | 4,573 | -4.6% | 0.00% | – |
| Q2 2021 | $101,000 | -34.0% | 4,793 | -11.9% | 0.00% | – |
| Q1 2021 | $153,000 | -64.5% | 5,443 | -67.1% | 0.00% | -100.0% |
| Q4 2020 | $431,000 | -47.5% | 16,566 | -25.0% | 0.00% | -50.0% |
| Q3 2020 | $821,000 | +101.2% | 22,095 | +178.1% | 0.00% | +100.0% |
| Q2 2020 | $408,000 | +81.3% | 7,946 | +11.3% | 0.00% | 0.0% |
| Q1 2020 | $225,000 | -38.9% | 7,140 | +15.9% | 0.00% | 0.0% |
| Q4 2019 | $368,000 | +231.5% | 6,159 | +103.3% | 0.00% | – |
| Q3 2019 | $111,000 | -22.9% | 3,030 | -2.3% | 0.00% | – |
| Q2 2019 | $144,000 | +16.1% | 3,100 | 0.0% | 0.00% | – |
| Q1 2019 | $124,000 | -74.5% | 3,100 | -70.8% | 0.00% | -100.0% |
| Q4 2018 | $487,000 | +4.1% | 10,600 | +0.7% | 0.00% | +100.0% |
| Q3 2018 | $468,000 | -10.7% | 10,530 | -21.3% | 0.00% | -50.0% |
| Q2 2018 | $524,000 | -55.7% | 13,378 | -18.2% | 0.00% | -50.0% |
| Q1 2018 | $1,182,000 | +61.5% | 16,346 | +46.9% | 0.00% | +100.0% |
| Q4 2017 | $732,000 | +32.1% | 11,124 | +0.7% | 0.00% | 0.0% |
| Q3 2017 | $554,000 | +21.2% | 11,051 | +12.1% | 0.00% | 0.0% |
| Q2 2017 | $457,000 | +32.8% | 9,856 | +1.1% | 0.00% | +100.0% |
| Q1 2017 | $344,000 | +182.0% | 9,752 | 0.0% | 0.00% | – |
| Q4 2016 | $122,000 | -9.6% | 9,752 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $135,000 | -10.6% | 9,752 | -36.3% | 0.00% | 0.0% |
| Q2 2016 | $151,000 | -41.7% | 15,320 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $259,000 | +37.0% | 15,320 | +80.2% | 0.00% | 0.0% |
| Q4 2015 | $189,000 | -23.8% | 8,500 | -19.0% | 0.00% | 0.0% |
| Q3 2015 | $248,000 | -71.2% | 10,500 | -0.2% | 0.00% | -66.7% |
| Q2 2015 | $860,000 | -11.5% | 10,522 | +0.2% | 0.00% | -25.0% |
| Q1 2015 | $972,000 | +128.7% | 10,500 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $425,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |